RJA
AGN

Raymond James & Associates’s Allergan Inc AGN Stock Holding History

Raymond James & Associates’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-19,350
Closed -$3.45M – 2412
2014
Q3 		$3.45M Buy
19,350
+1,286
+7% +$214K 0.02% 801
2014
Q2 		$3.06M Sell
18,064
-17,862
-50% -$2.78M 0.02% 867
2014
Q1 		$4.46M Buy
35,926
+1,868
+5% +$227K 0.03% 625
2013
Q4 		$3.78M Buy
34,058
+12,994
+62% +$1.24M 0.03% 637
2013
Q3 		$1.91M Buy
21,064
+844
+4% +$75.8K 0.02% 911
2013
Q2 		$1.7M Buy
+20,220
New +$2.1M 0.02% 897

Other funds holding AGN

PSCM
Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return
LTI
Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Raymond James & Associates's AGN Position: Q4 2014 in Review

Raymond James & Associates sold out of Allergan Inc (AGN) in Q4 2014, closing a stake of 19,350 shares — an estimated $3.45M sold.

Raymond James & Associates first reported a position in AGN in Q2 2013 and held it in 6 quarters. The position peaked at $4.46M in Q1 2014. 819 funds tracked by Wall St. Rank hold AGN as of Q4 2014.

  • Raymond James & Associates reported no remaining Allergan Inc position as of Q4 2014 after selling out during the quarter.
  • Raymond James & Associates sold 19,350 Allergan Inc shares in Q4 2014, an estimated $3.45M.
  • Raymond James & Associates first reported a position in Allergan Inc in Q2 2013 and held it in 6 quarters.
  • Raymond James & Associates's Allergan Inc position peaked at $4.46M in Q1 2014.
  • 819 funds tracked by Wall St. Rank held Allergan Inc as of Q4 2014.

Based on Raymond James & Associates's 13F filing for Q4 2014, filed 11 Feb 2015.